BioPorto Diagnostics - Buy antibodies, immunoassays and a market-leading acute kidney injury biomarker, The NGAL Test - use both human urine and plasma.

Biotechnology

BioPorto Diagnostics

BioPorto Diagnostics' headquarters in Hellerup, Denmark

Peter Mørch Eriksen

Nis Glavind Kruse

Helle Helena Kirkemann

Jennifer Zonderman

Thomas Arvedsen

Asger Dahlgaard

Thomas Magnussen

Torben A. Nielsen

Kirsten Aarup Drejer

Christopher Lindop

Michael S. Singer

The Laboratory and Research Team at BioPorto Diagnostics conducts essential scientific investigations and develops innovative diagnostic solutions. They perform experiments, validate assays like the NGAL Test, and collaborate to enhance and diversify BioPorto's product offerings. Comprising specialists like Laboratory Scientists and Research Scientists, they ensure the rigorous testing and application of immunoassays and biomarkers for acute kidney injury diagnosis.

Laboratory and Research Team

The Leadership Team at BioPorto Diagnostics is responsible for setting strategic direction and overseeing the company's operations, ensuring compliance with quality and regulatory standards, driving global medical initiatives, and managing financial reporting. They collaborate to enhance the commercialization of innovative diagnostic solutions, including the NGAL Test for acute kidney injury, while fostering growth and development in the global market.

BioPorto Diagnostics

Org chart

Board & advisors

Teams

Laboratory and Research Team

Leadership Team

Offices

BioPorto Diagnostics

Org chart

Board & advisors

Teams

Laboratory and Research Team

Leadership Team

Offices

Related companies